Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.16.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.9.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.9.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.517NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.517NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.291NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.291NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.349NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.349NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.314NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.314NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.132NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.132NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.38NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.42NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.42NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
K.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
K.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.56NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.56NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KF.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KF.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
B.1.263NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.263NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.180NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.180NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.464NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.464NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.234NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.234NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.231NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.231NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.243NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.243NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.302NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.302NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.222NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.222NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.434NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.434NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.467NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.467NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.110.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.110.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.23 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used